by DONALD E. FRANCKE
LEVELS OF PHARMACY PRACTICE
ONE CAN IDENTIFY SEVERAL levels of practice in pharmacy and one such arbitrary classification is shown in Table 1 . The criteria I used to judge the five levels of practice was whether 90 percent of one level could perform 90 percent of the responsibilities of the next higher level. If they could not then they are separate levels; if they could, I merged the levels. For example, I believe there is a significant difference between the levels of practice of what the Millis Commission called a generic pharmacist and what I call a clinical pharmacist generalist and that 90 percent of the present generic pharmacists cannot carry out 90 percent of the responsibilities of the clinical pharmacist generalist. In the same way, I believe that 90 percent of the clinical pharmacist generalists cannot carry out the responsibilities of 90 percent of the pharmacotherapeutic specialists or applied pharmacologists. However, until levels of competency are determined and applied, any graduate can continue to claim any level of competency in professional practice he chooses.
At present, an underdeveloped area of pharmacy practice is that performed by the clinical scientist who in the words of the Millis Commission is "equally at home at the patient's bedside or in the laboratory." 1 The use of the term laboratory has generated a great deal of confusion as to the nature of the clinical scientist and how he will be developed and I am now seeking clarification of this point. However, if we relate the clinical scientist in medicine to the clinical scientist in pharmacy what do we find. First that the large majority of physicians who are clinical scientists possess only their basic professional degree; a few also have a research degree. Second, physicians with this background perform significant research in such fields as lipid research, cancer research, hematology, hypertension and many others. Third, the research team is almost always multidisciplinary and numerous specialists contribute. Fourth, the physician, since he bears the chief responsibility for the patient, is the leader of the research team. It would be my judgment that clinical scientists in pharmacy will develop in somewhat the same manner. A number of those who receive good training in the basic sciences, who have the appropriate motivation, who possess excellent clinical training and who have a proper health care setting for research involvement will become clinical scientists without too much additional formalized effort.
A second level of practice is that which I would call areas of specialization as exemplified by the Fharmacoiherapeutic Specialist or Applied Pharmacologist. In the early days of clinical pharmacy education, I attempted to conceptualize what a clinical pharmacist was and thought of him as an applied pharmacologist. I thought of the clinical pharmacist as being a person who, in addition to his basic pharmacology, had taken courses in pharmacology and therapeutics with medical students, courses in which he would receive a great deal of therapeutics. I thought of him as having graduate level courses in biostatistics, pathophysiology, biopharmaceutics and pharmacokinetics, and the sociology of health care. These courses plus his general educational background in microbiology, pharmaceutics, formulation, etc., plus suitable clinical training such as a residency or clerkship would produce one of the most drug knowledgeable people on the health care team. Some people don't like calling the clinical pharmacist an applied pharmacologist 534 EDITORIAL because they think it might antagonize clinical pharmacologists. Thus, I also think of the clinical pharmacist as a pharmacotherapeutic specialist. The important considerations, I believe, are his knowledge of therapeutics and the actions of drugs in humans. In the preface to the first edition of Applied Pharmacology which the British physician, A. J. Clark, wrote more than fifty years ago, he said that his objective was "to give an account of the direct scientific evidence for the therapeutic action of the most important drugs, and to demonstrate the importance of this knowledge in the clinical application of drugs." 2 This is essentially the objective of the high level clinical pharmacist whether one calls him a pharmacotherapeutic specialist or an applied pharmacologist.
Of course a number of other specialists may eventually be approved after due consideration by the APhA's Board of Pharmaceutical Specialties. 3 Some of these may be, for example, Clinical Radiopharmacist Specialist, Drug Information Specialist, Pédiatrie Clinical Pharmacy Specialist, Geriatric Clinical Pharmacist, and perhaps others. However, I would expect that the large umbrella for the areas of specialization would be the Pharmacotherapeutic Specialist or Applied Pharmacologist, or some similar designation. For example, I would expect this person's knowledge and experience would be such that he would be equally at home with patients and physicians in such specialties as medicine, surgery, obstetrics and gynecology, neurology, etc. The principal reason pédiatrie and geriatric clinical pharmacy may be eventually judged as specialties is because of the differences in metabolism of drugs in the very young and very old. Whether this difference warrants specialization remains to be seen.
A third level of pharmacy practice is exemplified by the clinical pharmacy generalist. As this title implies, this person is a generalist with a broad range of knowledge. This person is not as well grounded as the applied pharmacologist in pharmacology, therapeutics, biostatistics or pharmacokinetics and lacks his clinical training and experience. Still he has a sufficient background to be a most valuable member of the health care team.
A fourth level of practice is that exemplified by the hundreds of what the Millis Commission describes as generic pharmacists who practice in community and hospital pharmacies. Some of these are involved in a high percentage of professional activities and are engaged in daily patient-physician contacts and perform numerous important clinical services for patients and the health team. In due course, I anticipate that this level will merge with the clinical pharmacy generalist as the colleges improve their educational programs and decrease their student load.
In addition, there is a fifth level of practice carried out by generic pharmacists who are involved in a low percentage of professional activities and perform few if any clinical functions. These are the pharmacists who stand behind a counter all day repetitively filling and labeling prescriptions, turning the filled prescription over to a clerical person to transfer to the patient. I would like to see the profession recognize that it does not require the training a pharmacist receives to carry out the functions now performed by a large number of pharmacists. Once this was accepted, the number of pharmacists enrolled in schools of pharmacy could be greatly decreased. On the other hand, the importance and significance of the pharmacist would be greatly enhanced because they would be trained to perform tasks which are now neglected. Schools of pharmacy would have fewer pharmacy students but they would be superior students trained to an entirely different level than they are at present. The education and training of these students would be such that a professional doctoral degree would be entirely appropriate. Schools of pharmacy would be involved, directly or indirectly, in the training of technical personnel to the level required by the function they will be called upon to perform. I believe that this is the general pattern that will finally emerge and when it does, pharmacy will become a much stronger profession because of it.
